modafinil has been researched along with Necrosis in 1 studies
Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.
Necrosis: The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Modafinil 25 mg/kg was the most effective dose (PNA: 26 [95% CI: 19-33]) vs." | 1.62 | Protective effect of modafinil on skin flap survival in the experimental random-pattern skin flap model in rats: The role of ATP-sensitive potassium channels and nitric oxide pathway. ( Abbasi, A; Araghi, F; Aryannejad, A; Dehpour, AR; Gandominejad, A; Mohammad Jafari, R; Noroozi, N; Tabary, M, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aryannejad, A | 1 |
| Gandominejad, A | 1 |
| Tabary, M | 1 |
| Noroozi, N | 1 |
| Abbasi, A | 1 |
| Araghi, F | 1 |
| Mohammad Jafari, R | 1 |
| Dehpour, AR | 1 |
1 other study available for modafinil and Necrosis
| Article | Year |
|---|---|
Protective effect of modafinil on skin flap survival in the experimental random-pattern skin flap model in rats: The role of ATP-sensitive potassium channels and nitric oxide pathway.
Topics: Animals; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Graft Survival; Inject | 2021 |